Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Other Non-Current Liabilities 2010-2025 | PRPH

ProPhase Labs other non-current liabilities from 2010 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  
ProPhase Labs Annual Other Non-Current Liabilities
(Millions of US $)
2024 $5
2023 $5
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
ProPhase Labs Quarterly Other Non-Current Liabilities
(Millions of US $)
2025-03-31 $2
2024-12-31 $2
2024-09-30 $2
2024-06-30 $2
2024-03-31
2023-12-31 $5
2023-09-30 $2
2023-06-30 $2
2023-03-31 $2
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.043B 28.90
Zoetis (ZTS) United States $70.699B 26.38
Takeda Pharmaceutical (TAK) Japan $47.220B 9.39
Daiichi Sankyo, - (DSNKY) Japan $41.486B 21.26
BeOne Medicines - (ONC) Cayman Islands $27.772B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $19.220B 0.00
Merck (MKKGY) Germany $17.273B 12.66
Shionogi (SGIOY) Japan $14.343B 14.37
United Therapeutics (UTHR) United States $13.539B 11.98
Neurocrine Biosciences (NBIX) United States $13.352B 45.74
Orion OYJ (ORINY) Finland $11.119B 30.07
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.856B 48.04
Corcept Therapeutics (CORT) United States $7.636B 62.08
Madrigal Pharmaceuticals (MDGL) United States $6.986B 0.00
Ionis Pharmaceuticals (IONS) United States $6.745B 0.00
Grifols, S.A (GRFS) Spain $6.704B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.048B 0.00
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $2.995B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.665B 9.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.630B 14.22
NewAmsterdam Pharma (NAMS) Netherlands $2.472B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.957B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.858B 0.00
ARS Pharmaceuticals (SPRY) United States $1.766B 0.00
Ocular Therapeutix (OCUL) United States $1.765B 0.00
Endo (NDOI) United States $1.602B 0.00
ProKidney (PROK) United States $1.516B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
Guardian Pharmacy Services (GRDN) United States $1.319B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.206B 24.14
Harrow (HROW) United States $1.151B 0.00
Ardelyx (ARDX) United States $1.125B 0.00
Enliven Therapeutics (ELVN) United States $1.118B 0.00
Collegium Pharmaceutical (COLL) United States $1.060B 5.72
Akebia Therapeutics (AKBA) United States $1.045B 0.00
Dyne Therapeutics (DYN) United States $1.000B 0.00
Verve Therapeutics (VERV) United States $0.986B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.945B 0.00
Xeris Biopharma Holdings (XERS) United States $0.824B 0.00
Cronos Group (CRON) Canada $0.810B 0.00
KalVista Pharmaceuticals (KALV) United States $0.771B 0.00
Xencor (XNCR) United States $0.660B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.659B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Relay Therapeutics (RLAY) United States $0.639B 0.00
USANA Health Sciences (USNA) United States $0.622B 13.53
Bioventus (BVS) United States $0.607B 15.40
Theravance Biopharma (TBPH) United States $0.573B 0.00
Organogenesis (ORGO) United States $0.558B 0.00
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Oruka Therapeutics (ORKA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.493B 10.30
Tourmaline Bio (TRML) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.398B 0.00
Altimmune (ALT) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.47
Heron Therapeutics (HRTX) United States $0.339B 0.00
AleAnna (ANNA) United States $0.315B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.312B 0.00
Nektar Therapeutics (NKTR) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 26.52
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
OmniAb (OABI) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.247B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
MediWound (MDWD) Israel $0.228B 0.00
Larimar Therapeutics (LRMR) United States $0.223B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.198B 0.00
Liminatus Pharma (LIMN) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Avita Medical (RCEL) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.152B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Lyell Immunopharma (LYEL) United States $0.145B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Champions Oncology (CSBR) United States $0.122B 20.02
Protara Therapeutics (TARA) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.081B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.081B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Klotho Neurosciences (KLTO) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.072B 0.00
Dominari Holdings (DOMH) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Jupiter Neurosciences (JUNS) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.11
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Vivos Therapeutics (VVOS) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 2.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00